2022
Thoracic CT follow-up after non-small-cell lung cancer resection
Woodard G, Boffa D, Blasberg J. Thoracic CT follow-up after non-small-cell lung cancer resection. The Lancet Oncology 2022, 23: e484. PMID: 36328013, DOI: 10.1016/s1470-2045(22)00618-0.Commentaries, Editorials and LettersCarcinoma, Non-Small-Cell LungFollow-Up StudiesHumansLung NeoplasmsPneumonectomyRetrospective StudiesTomography, X-Ray Computed
2020
Invasive Staging Procedures Do Not Prevent Nodal Metastases From Being Missed in Stage I Lung Cancer
Resio BJ, Canavan M, Mase V, Dhanasopon AP, Blasberg JD, Boffa DJ. Invasive Staging Procedures Do Not Prevent Nodal Metastases From Being Missed in Stage I Lung Cancer. The Annals Of Thoracic Surgery 2020, 110: 390-397. PMID: 32283084, DOI: 10.1016/j.athoracsur.2020.03.026.Peer-Reviewed Original ResearchConceptsStage I lung cancerI lung cancerMissed nodal metastasisClinical stage I lung cancerNodal metastasisLung cancerPositron emission tomographyStaging evaluationCancer patientsEndobronchial ultrasoundInvasive nodalClinical stage I patientsEarly-stage lung cancer patientsOccult lymph node metastasisEmission tomographyThoracic Surgeons General Thoracic Surgery DatabaseInvasive staging proceduresClinical stage IStage I patientsTreatment-naive patientsGeneral Thoracic Surgery DatabaseLow-risk cohortOccult nodal metastasisLymph node metastasisLung cancer patients
2019
Short Tandem Repeats Define a Gestational Origin for Metastatic Choriocarcinoma
Brown K, Homer R, Baine M, Blasberg JD. Short Tandem Repeats Define a Gestational Origin for Metastatic Choriocarcinoma. The Annals Of Thoracic Surgery 2019, 108: e115-e117. PMID: 30685255, DOI: 10.1016/j.athoracsur.2018.12.038.Peer-Reviewed Original ResearchConceptsPlacenta accretaSpontaneous hemothoraxGestational choriocarcinomaLower lobe massMetastatic gestational choriocarcinomaHealthy female patientsAdjuvant therapyMetastatic choriocarcinomaSurgical explorationChief complaintFemale patientsOutside hospitalRare consequenceUnreported causeGestational originClinical implicationsChoriocarcinomaAccretaHemothoraxResectionPatientsPrognosisHospitalShortnessTherapy
2018
Seeing through the ground-glass: Do imaging characteristics really matter?
Blasberg JD, Resio B. Seeing through the ground-glass: Do imaging characteristics really matter? Journal Of Thoracic And Cardiovascular Surgery 2018, 156: 1677-1678. PMID: 30098805, DOI: 10.1016/j.jtcvs.2018.06.055.Peer-Reviewed Original ResearchEvaluation of ground glass nodules
Mironova V, Blasberg JD. Evaluation of ground glass nodules. Current Opinion In Pulmonary Medicine 2018, 24: 350-354. PMID: 29634577, DOI: 10.1097/mcp.0000000000000492.Peer-Reviewed Original ResearchMeSH KeywordsDiagnosis, DifferentialDisease ProgressionHumansLung NeoplasmsSolitary Pulmonary NoduleTomography, X-Ray ComputedTumor BurdenWatchful WaitingConceptsGround-glass nodulesLocal treatment optionsCAT scanTreatment optionsLung cancerMediastinal windowEarly-stage lung cancerNonsmall cell lung cancerGlass nodulesChest CAT scansHigh-risk patientsLarge prospective studiesSingle-institution dataSignificant solid componentSolid componentsSurgical resectionFavorable prognosisProspective studyInterval imagingImaging featuresDistinguish patientsNodule progressionLower riskSignificant progressionPatients
2016
Chest Discomfort and Longstanding Dyspnea on Exertion
Macke RA, Templin TP, Blasberg JD. Chest Discomfort and Longstanding Dyspnea on Exertion. JAMA Surgery 2016, 151: 979-980. PMID: 27533325, DOI: 10.1001/jamasurg.2016.2043.Peer-Reviewed Original ResearchAdultChest PainDiaphragmDyspneaHumansMalePhysical ExertionRuptureTomography, X-Ray ComputedWounds, Nonpenetrating
2012
Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population
Joseph S, Harrington R, Walter D, Goldberg JD, Li X, Beck A, Litton T, Hirsch N, Blasberg J, Slomiany M, Rom W, Pass H, Donington J. Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomarkers 2012, 12: 177-184. PMID: 23568008, PMCID: PMC3746829, DOI: 10.3233/cbm-130306.Peer-Reviewed Original ResearchConceptsIncident cancerPlasma osteopontinNon-small cell lung cancer careLung cancer careCase-control studySerial plasmaNSCLC patientsCT screeningSurveillance intervalsCancer careLung cancerPlasma levelsWilcoxon Signed Rank TestDisease statusCancerSigned Rank TestBenign nodulesSecreted phosphoproteinCTRank testOsteopontinEarly evidenceNSCLCPatientsNSCLCs
2010
Robotic Brachytherapy and Sublobar Resection for T1 Non-Small Cell Lung Cancer in High-Risk Patients
Blasberg JD, Belsley SJ, Schwartz GS, Evans A, Wernick I, Ashton RC, Bhora FY, Connery CP. Robotic Brachytherapy and Sublobar Resection for T1 Non-Small Cell Lung Cancer in High-Risk Patients. The Annals Of Thoracic Surgery 2010, 89: 360-367. PMID: 20103299, DOI: 10.1016/j.athoracsur.2009.09.052.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAgedAged, 80 and overBrachytherapyCombined Modality TherapyComorbidityDisease ProgressionFemaleFollow-Up StudiesHealth Status IndicatorsHumansImage Processing, Computer-AssistedIodine RadioisotopesLung NeoplasmsMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPneumonectomyPositron-Emission TomographyPostoperative ComplicationsRadiometryRadiotherapy DosageRadiotherapy Planning, Computer-AssistedRadiotherapy, AdjuvantRoboticsTomography, X-Ray ComputedConceptsNon-small cell lung cancerHigh-risk patientsCell lung cancerPlanning target volumeSublobar resectionLung cancerPrescription doseStage IA non-small cell lung cancerTarget volumeT1 non-small cell lung cancerSublobar lung resectionPatients 5 yearsSite of recurrenceIncidence of recurrenceComputed tomography scanBrachytherapy seed placementDa Vinci systemConventional lobectomyPerioperative mortalityLocoregional recurrenceLung resectionSelect patientsLimited resectionResection marginsTumor size